What is the maximum recommended daily dose of ibuprofen for adults, children (by weight), and elderly patients, and are there any contraindications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Dose of Ibuprofen

The maximum daily dose of ibuprofen is 2400 mg per day for adults, administered as 400–800 mg every 6 hours, with lower doses (1200 mg/day) sufficient for mild-to-moderate pain and higher prescription doses (1800–2400 mg/day) reserved for inflammatory conditions requiring close monitoring. 1

Adult Dosing

Standard Dosing by Indication

  • For mild-to-moderate pain: 400 mg every 4–6 hours, with a maximum of 1200 mg per day for over-the-counter use 1, 2
  • For anti-inflammatory effects (e.g., back pain, migraine): 400–800 mg every 6 hours, not exceeding 2400 mg per day 1, 3
  • Single dose maximum: 800 mg 1

Duration Considerations

  • Acute pain conditions: Use for 5–10 days maximum 1
  • Chronic use beyond 10 days: Requires mandatory monitoring every 3 months (blood pressure, renal function, liver enzymes, CBC, fecal occult blood) 1, 3

Pediatric Dosing

Weight-Based Dosing

  • Standard dose: 5–10 mg/kg per dose, administered every 6 hours 4, 5
  • Maximum single dose: 400 mg for children under 40 kg; 800 mg for children over 40 kg 1
  • Maximum daily dose: 30–40 mg/kg per day, not exceeding 2400 mg 4
  • Children weighing ≥40 kg: Use adult dosing 1, 6

Age-Specific Considerations

  • Infants 3–6 months: Safe for short-term use if body weight >5–6 kg, with special attention to hydration; dose 5–10 mg/kg every 6–8 hours 4
  • Infants <3 months: Not adequately evaluated; avoid use 4
  • Liquid formulations preferred for children <40 kg to ensure accurate weight-based dosing 1

Elderly Patients

Dose Adjustments

  • Patients ≥60 years: Increased risk of all NSAID-related adverse effects; use lowest effective dose for shortest duration 1, 3
  • Patients ≥65 years: Consider dose reduction to 100 mg/day or avoid entirely, particularly in nursing home residents 7
  • Alternative: Topical NSAIDs or acetaminophen (up to 3000 mg/day) preferred in high-risk elderly 1

Absolute Contraindications

  • Active peptic ulcer disease or gastrointestinal bleeding 3
  • Aspirin/NSAID-induced asthma 1
  • Third trimester pregnancy 3
  • Perioperative pain in coronary artery bypass graft surgery 1
  • Heart failure (avoid entirely) 1
  • Severe renal impairment (creatinine clearance <10 mL/min) 7

High-Risk Populations Requiring Extreme Caution

Cardiovascular and Renal Risk

  • Hypertension: Ibuprofen increases blood pressure by mean of 5 mm Hg; monitor closely 1
  • Renal dysfunction, cirrhosis, or compromised fluid status: Risk of acute kidney injury; consider alternative analgesics 1, 3
  • Age >60 years with any renal risk factors: Markedly increased risk of renal impairment 1

Gastrointestinal Risk

  • History of peptic ulcer disease: 5% risk of recurrent bleeding within 6 months even with protective measures 1
  • Concomitant anticoagulant use (warfarin, heparin): 5–6 times increased GI bleeding risk 1, 3
  • Concomitant corticosteroids or SSRIs: Increased GI bleeding risk 1
  • One-year serious GI bleeding risk: Ranges from 1 in 2,100 (age <45 years) to 1 in 110 (age >75 years) 1

Risk Mitigation Strategies

  • Add proton pump inhibitor for patients with history of peptic ulcer disease 1
  • Consider COX-2 inhibitors as alternative in high GI risk patients 1
  • Use topical NSAIDs (diclofenac gel/patch) for localized pain to minimize systemic exposure 1

Critical Drug Interactions

  • Low-dose aspirin for cardioprotection: Take ibuprofen at least 30 minutes AFTER immediate-release aspirin or at least 8 hours BEFORE aspirin to avoid interfering with aspirin's antiplatelet effect 1
  • Kawasaki disease patients on aspirin: Ibuprofen is contraindicated as it antagonizes aspirin-induced platelet inhibition 1
  • Nephrotoxic agents (cyclosporine, cisplatin): Heightened risk of renal impairment; close monitoring or avoidance required 3

Mandatory Monitoring for Chronic Use (>10 Days)

Monitoring Parameters Every 3 Months

  • Blood pressure 1, 3
  • Renal function (BUN, creatinine) 1, 3
  • Liver function tests (AST, ALT, alkaline phosphatase, LDH) 1, 3
  • Complete blood count 1, 3
  • Fecal occult blood testing 1, 3

Discontinuation Criteria

Stop ibuprofen immediately if any of the following occur:

  • BUN or creatinine doubles 1, 3
  • Hypertension develops or worsens 1, 3
  • Liver function tests increase to 3× upper limit of normal 3
  • Gastrointestinal bleeding (positive fecal occult blood, overt bleeding) 1, 3
  • Signs of acute kidney injury (decreased urine output, rising creatinine, fluid retention) 1
  • Worsening asthma symptoms 1

Alternative Strategies

When to Consider Alternatives

  • Neuropathic pain component: Add gabapentin (900–3600 mg/day) or pregabalin (150–300 mg/day) rather than increasing ibuprofen dose 1
  • Localized osteoarthritis: Topical NSAIDs to minimize systemic exposure 1
  • High-risk patients: Acetaminophen up to 3000 mg/day as safer alternative, though slightly less effective 1
  • Two NSAIDs fail in succession: Switch to opioid analgesics or non-pharmacologic interventions rather than trialing additional NSAIDs 3

Common Pitfalls to Avoid

  • Infants <1 year: More likely to receive inaccurate doses; caregivers should base dosing on weight, not age 8
  • "Hidden sources" of NSAIDs: Account for combination medications to avoid excessive total NSAID exposure 1
  • Rectal route in young infants: Less reliable due to erratic absorption 4
  • Taking with food: May improve gastrointestinal tolerability 3, 2

References

Guideline

Maximum Daily Dosing of Ibuprofen in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Ibuprofen: pharmacology, efficacy and safety.

Inflammopharmacology, 2009

Guideline

Ibuprofen Use: Risk Assessment, Monitoring, and Discontinuation Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

A general overview of the use of ibuprofen in paediatrics.

International journal of clinical practice. Supplement, 2003

Guideline

Racecadotril Dosing Guidelines for Patients at or Above 40kg

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Acetaminophen and ibuprofen dosing by parents.

Pediatric emergency care, 2000

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.